552 related articles for article (PubMed ID: 25534943)
1. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract.
Koenigsknecht MJ; Theriot CM; Bergin IL; Schumacher CA; Schloss PD; Young VB
Infect Immun; 2015 Mar; 83(3):934-41. PubMed ID: 25534943
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of early stages of Clostridium difficile infection: germination and colonization.
Sarker MR; Paredes-Sabja D
Future Microbiol; 2012 Aug; 7(8):933-43. PubMed ID: 22913353
[TBL] [Abstract][Full Text] [Related]
3. Intestinal calcium and bile salts facilitate germination of Clostridium difficile spores.
Kochan TJ; Somers MJ; Kaiser AM; Shoshiev MS; Hagan AK; Hastie JL; Giordano NP; Smith AD; Schubert AM; Carlson PE; Hanna PC
PLoS Pathog; 2017 Jul; 13(7):e1006443. PubMed ID: 28704538
[TBL] [Abstract][Full Text] [Related]
4. A new strategy for the prevention of Clostridium difficile infection.
Howerton A; Patra M; Abel-Santos E
J Infect Dis; 2013 May; 207(10):1498-504. PubMed ID: 23420906
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.
Theriot CM; Bowman AA; Young VB
mSphere; 2016; 1(1):. PubMed ID: 27239562
[TBL] [Abstract][Full Text] [Related]
6. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes.
Plaza-Garrido Á; Miranda-Cárdenas C; Castro-Córdova P; Olguín-Araneda V; Cofré-Araneda G; Hernández-Rocha C; Carman R; Ibáñez P; Fawley WN; Wilcox MH; Gil F; Calderón IL; Fuentes JA; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333
[TBL] [Abstract][Full Text] [Related]
7. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection.
Reeves AE; Theriot CM; Bergin IL; Huffnagle GB; Schloss PD; Young VB
Gut Microbes; 2011; 2(3):145-58. PubMed ID: 21804357
[TBL] [Abstract][Full Text] [Related]
8. Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.
Warn P; Thommes P; Sattar A; Corbett D; Flattery A; Zhang Z; Black T; Hernandez LD; Therien AG
Antimicrob Agents Chemother; 2016 Nov; 60(11):6471-6482. PubMed ID: 27527088
[TBL] [Abstract][Full Text] [Related]
9. Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions.
Kochan TJ; Shoshiev MS; Hastie JL; Somers MJ; Plotnick YM; Gutierrez-Munoz DF; Foss ED; Schubert AM; Smith AD; Zimmerman SK; Carlson PE; Hanna PC
mSphere; 2018 Sep; 3(5):. PubMed ID: 30185513
[No Abstract] [Full Text] [Related]
10. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.
Thanissery R; Winston JA; Theriot CM
Anaerobe; 2017 Jun; 45():86-100. PubMed ID: 28279860
[TBL] [Abstract][Full Text] [Related]
11. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
12. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.
Buffie CG; Jarchum I; Equinda M; Lipuma L; Gobourne A; Viale A; Ubeda C; Xavier J; Pamer EG
Infect Immun; 2012 Jan; 80(1):62-73. PubMed ID: 22006564
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.
Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Wilcox MH
J Antimicrob Chemother; 2015 Aug; 70(8):2316-21. PubMed ID: 25925596
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Bacterial Communities during Clostridium difficile Infection in the Mouse.
Semenyuk EG; Poroyko VA; Johnston PF; Jones SE; Knight KL; Gerding DN; Driks A
Infect Immun; 2015 Nov; 83(11):4383-91. PubMed ID: 26324536
[TBL] [Abstract][Full Text] [Related]
15. Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection.
Chilton CH; Crowther GS; Śpiewak K; Brindell M; Singh G; Wilcox MH; Monaghan TM
J Antimicrob Chemother; 2016 Apr; 71(4):975-85. PubMed ID: 26759363
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile colitis: pathogenesis and host defence.
Abt MC; McKenney PT; Pamer EG
Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
[TBL] [Abstract][Full Text] [Related]
17. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
[TBL] [Abstract][Full Text] [Related]
18. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
[TBL] [Abstract][Full Text] [Related]
19. Updates on Clostridium difficile spore biology.
Gil F; Lagos-Moraga S; Calderón-Romero P; Pizarro-Guajardo M; Paredes-Sabja D
Anaerobe; 2017 Jun; 45():3-9. PubMed ID: 28254263
[TBL] [Abstract][Full Text] [Related]
20. Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.
Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Baines SD; Wilcox MH
J Antimicrob Chemother; 2014 Aug; 69(8):2137-47. PubMed ID: 24788662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
